Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Deferred Tax Assets / Liabilities ₹4.98 Cr₹4.42 Cr₹4.58 Cr₹7.16 Cr₹5.85 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Deferred Tax Assets / Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹4.98 Cr based on Mar2024 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2024₹4.98 Cr
Mar2023₹4.42 Cr
Mar2022₹4.58 Cr
Mar2017₹7.16 Cr
Mar2016₹5.85 Cr

How is Deferred Tax Assets / Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2024 ₹4.98 Cr
12.55
Mar2023 ₹4.42 Cr
-3.34
Mar2022 ₹4.58 Cr
-36.07
Mar2017 ₹7.16 Cr
22.41
Mar2016 ₹5.85 Cr -

Compare Deferred Tax Assets / Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,788.8 Cr -6.1% -2.3% 52.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹398,686.0 Cr 0.8% -1.3% 10.6% Stock Analytics
DIVIS LABORATORIES ₹176,075.0 Cr 1.5% 2.3% 47.2% Stock Analytics
CIPLA ₹121,023.0 Cr -0.3% 0.9% -3.8% Stock Analytics
DR REDDYS LABORATORIES ₹109,971.0 Cr -0.1% 7.2% 11.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,121.0 Cr -2.7% -0.3% 9.9% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-6.1%

-2.3%

52.8%

SENSEX

0.1%

1.2%

6%


You may also like the below Video Courses